Role of Nef in primate lentiviral immunopathogenesis

Cellular and Molecular Life Sciences

Volumn 65, Issue 17, 2008, Pages 2621-2636

  Kirchhoff, F ^a   Schindler, M ^a,b   Specht, A ^a   Arhel, N ^a   Munch J ^a  

^a UNIVERSITY OF ULM   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

AIDS; HIV; Immunological synapse; Nef; Pathogenesis; Primate lentiviruses; SIV; Viral persistence

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN;

ANTIGEN PRESENTING CELL; ANTIGENIC MODULATION; DISEASE ASSOCIATION; DOWN REGULATION; GENE ACTIVITY; GENE FREQUENCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; NONHUMAN; PRIMATE; PROTEIN FUNCTION; RETROVIRUS INFECTION; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; DOWN-REGULATION; GENE PRODUCTS, NEF; HUMANS; LENTIVIRUS; PRIMATE DISEASES; RECEPTORS, ANTIGEN, T-CELL; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 51349141354     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8094-2     Document Type: Review

References (180)

1. Geyer M., Fackler O. T. and Peterlin B. M. (2001) Structure-function relationships in HIV-1 Nef. EMBO Rep. 2, 580-585.
2. Kestler H. W., Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D. and Desrosiers R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
3. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D.J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D. and Mills J. (1995) Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991.
4. Kirchhoff F., Greenough T. C., Brettler D. B., Sullivan J. L. and Desrosiers R.C. (1995) Absence of intact nef sequences in a long-term, nonprogressing survivor of HIV-1 infection. N. Engl. J. Med. 332, 228-232.
5. Salvi A., Garbuglia R., Di Caro A., Pulciani S., Montella F. and Benedetto A. (1998) Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J. Virol. 72, 3646-3657.
6. Gorry P. R., Churchill M., Learmont J., Cherry C., Dyer W. B., Wesselingh S. L. and Sullivan J. S. (2007) Replication-dependent pathogenicity of attenuated nef-deleted HIV-1 in vivo. J. Acquir. Immune Defic. Syndr. 46, 390-394.
7. Greenough T. C., Sullivan J. L. and Desrosiers R. C. (1999) Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N. Engl. J. Med. 340, 236-237.
8. Baba T. W., Liska V., Khimani A. H., Ray N. B., Dailey P. J., Penninck, D. R., Bronson R., Greene M. F., McClure H. M., Martin L. N. and Ruprecht R. M. (1999) Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med. 5, 194-203.
9. Garcia J.V. and Miller A.D. (1991) Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511.
10. Schwartz O., Marechal, V., Le Gall S., Lemonnier F. and Heard J. M. (1996) Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338-342.
11. Stumptner-Cuvelette P., Morchoisne S., Dugast M., Le Gall S., Raposo G., Schwartz O. and Benaroch P. (2001) HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98, 12144-12149.
12. Chowers M. Y., Spina C. A., Kwoh T. J., Fitch N. J., Richman D. D. and Guatelli J. C. (1994) Optimal infectivity in vitro of HIV-1 requires an intact nef gene. J. Virol. 68, 2906-2914.
13. Miller M. D., Warmerdam M. T., Gaston I., Greene W. C. and Feinberg M. B. (1994) The HIV-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-114.
14. Spina C. A., Kwoh T. J., Chowers M. Y., Guatelli J. C. and Richman D. D. (1994) The importance of nef in the induction of HIV-1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-123.
15. Bell I., Ashman C., Maughan J., Hooker E., Cook F. and Reinhart T. A. (1998) Association of SIV Nef with the T cell receptor (TCR) zeta chain leads to TCR down modulation. J. Gen. Virol. 79, 2717-2727.
16. Howe A.Y., Jung J.U. and Desrosiers R. C. (1998) Zeta chain of the T cell receptor interacts with nef of SIV and HIV-2. J. Virol. 72, 9827-9834.
17. Swigut T., Shody N. and Skowronski J. (2001) Mechanism for down-regulation of CD28 by Nef. EMBO J. 20, 1593-1604.
18. Munch J., Schindler M., Wildum S., Rucker E., Bailer N., Knoop V., Müller-Trutwin M. C., Santiago M. L., Bibollet-Ruche F., Dittmar M. T., Heeney J. L., Hahn B. H. and Münch J. (2005) Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication. J. Virol. 79, 10547-10560.
19. Schindler M., Munch J., Kutsch O., Li H., Santiago M. L., Bibollet-Ruche F., Müller-Trutwin M. C., Novembre F. J., Peeters M., Courgnaud V., Bailes E., Roques P., Sodora D. L., Silvestri G., Sharp P. M., Hahn B. H. and Kirchhoff F. (2006) Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055-1067.
20. Das S.R. and Jameel S. (2005) Biology of the HIV Nef protein. Indian J. Med. Res. 121, 315-332.
21. Roeth J. F. and Collins K. L. (2006) Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70, 548-563.
22. Foster J. L. and Garcia J. V. (2007) Role of Nef in HIV-1 replication and pathogenesis. Adv. Pharmacol. 55, 389-409.
23. Renkema G. H. and Saksela K. (2000) Interactions of HIV-1 NEF with cellular signal transducing proteins. Front. Biosci. 5, 268-283.
24. Stove V. and Verhasselt B. (2006) Modelling thymic HIV-1 Nef effects. Curr. HIV Res. 4, 57-64.
25. Fackler O. T., Alcover A. and Schwartz O. (2007) Modulation of the immunological synapse: a key to HIV-1 pathogenesis? Nat. Rev. Immunol. 7, 310-317.
26. Benson R. E., Sanfridson A., Ottinger J. S., Doyle C. and Cullen B. R. (1993) Downregulation of cell-surface CD4 expression by SIV Nef prevents viral superinfection. J. Exp. Med. 177, 1561-1566.
27. Bell I., Schaefer T. M., Trible R. P., Amedee A. and Reinhart T. A. (2001) Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283, 148-158.
28. Swigut T., Iafrate A. J., Münch J., Kirchhoff F. and Skowronski J. (2000) SIV and HIV Nef proteins use different surfaces to downregulate class I major histocompatibility antigen expression. J. Virol. 74, 5691-5701.
29. Alexander L., Du Z., Rosenzweig M., Jung J. J. and Desrosiers R. C. (1997) A role for natural SIV and HIV-1 nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099.
30. Lang S. M., Iafrate A. J., Stahl-Hennig C., Kuhn E. M., Nißlein T., Haupt, M., Hunsmann G., Skowronski J. and Kirchhoff, F. (1997) Association of SIV Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3, 860-865.
31. Regier D.A. and Desrosiers R.C. (1989) The complete nucleotide sequence of a pathogenic molecular clone of SIV. AIDS Res. Hum. Retroviruses 6, 1221-1231.
32. Kestler H. W., Kodama T., Ringler D. J., Marthas M., Pedersen N., Lackner A., Regier D., Sehgal P., Daniel M., King N. and Desrosiers R. (1990) Induction of AIDS in rhesus monkeys by molecularly cloned SIV. Science 248, 1109-1112.
33. Kaur A., Grant R. M. Means R. E. McClue H., Feinberg M. and Johnson R. P. (1998) Diverse host responses and outcomes following SIV mac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72, 9597-9611.
34. Schindler M., Würfl S., Benaroch P., Greenough T. C., Daniels R. C., Easterbrook P., Brenner M., Münch J. and Kirchhoff F. (2003) Down-modulation of mature MHC class II and up-regulation of invariant chain cell surface expression are well conserved functions of HIV and SIV nef-alleles. J. Virol. 77, 10548-10556.
35. Akari H., Arold S., Fukumori T., Okazaki T., Strebel K. and Adachi A. (2000) Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J. Virol. 74, 2907-2912.
36. Craig H. M., Pandori M. W. and Guatelli J. C. (1998) Interaction of HIV 1 Nef with the cellular dileucine based sorting pathway is required for CD4 down regulation and optimal viral infectivity. Proc. Natl. Acad. Sci. USA 95, 11229-11234.
37. Greenberg M. E., Iafrate A. J. and Skowronski J. (1998) The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17, 2777-2789.
38. Iafrate A. J., Bronson S. and Skowronski J. (1997) Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684.
39. Le Gall S., Prevost M. C. Heard J. M. and Schwartz O. (1997) HIV-1 Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology 229, 295-301.
40. Lama, J. (2003) The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 1, 167-184.
41. Aiken C., Konner J., Landau N. R., Lenburg M. E. and Trono D. (1994) Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864.
42. Bresnahan P. A., Yonemoto W., Ferrell S., Williams-Herman D., Geleziunas R. and Greene W. C. (1998) A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Curr. Biol. 8, 1235-1238.
43. Greenberg M. E., DeTulleo L., Rapoport I., Skowronski J. and Kirchhausen T. (1998) A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr. Biol. 8, 1239-1242.
44. Mangasarian A., Foti M., Aiken C., Chin D., Carpentier J.-L. and Trono D. (1997) The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. Immunity 6, 67-77.
45. Piguet V., Chen Y.-L., Mangasarian A., Foti M., Carpentier J.-L. and Trono D. (1998) Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the m chain of adaptor complexes. EMBO J. 17, 2472-2481.
46. Kim Y. H., Chang S. H., Kwon J. H. and Rhee S. S. (1999) HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: Dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes. Virology 257, 208-219.
47. Geleziunas R., Bour S. and Wainberg M. A. (1994) Cell surface down-modulation of CD4 after infection by HIV-1. FASEB J. 8, 593-600.
48. Willey R. L., Maldarelli F., Martin M. A. and Strebel K. (1992) Human immunodeficiency virus type Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66, 226-234.
49. Willey R. L., Maldarelli F., Martin M. A. and Strebel K. (1992) Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.
50. Chen B. K., Gandhi R. T. and Baltimore D. (1996) CD4 downmodulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044-6053.
51. Wildum S., Schindler M., Munch J. and Kirchhoff F. (2006) Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J. Virol. 80, 8047-8059.
52. Iafrate A. J., Carl S., Bronson S., Stahl-Hennig C., Swigut T., Skowronski J. and Kirchhoff F. (2000) Disrupting surfaces of Nef required for downregulation of CD4 and for enhancement of virion infectivity attenuates simian immunodeficiency virus replication in vivo. J. Virol. 74, 9836-9844.
53. Brenner M., Münch J., Schindler M., Wildum S., Stolte N., Stahl-Hennig, C., Fuchs D., Mätz-Rensing K., Franz M., Heeney J., Ten Haaft P., Swigut T., Hrecka K., Skowronski J. and Kirchhoff F. (2006) Importance of the N-distal AP-2 binding element in Nef for simian immunodeficiency virus replication and pathogenicity in rhesus macaques. J. Virol. 80, 4469-4481.
54. Carl S., Daniels R., Iafrate A. J., Easterbrook P., Greenough T.C., Skowronski J. and Kirchhoff F. (2000) Partial "repair" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection. J. Infect. Dis. 181, 132-140.
55. Mariani R., Kirchhoff F., Greenough T. C., Sullivan J. L., Desrosiers R. C and Skowronski J. (1996) High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70, 7752-7764.
56. Tobiume M., Takahoko M., Yamada T., Tatsumi M., Iwamoto A. and Matsuda M. (2002) Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. J. Virol. 76, 5959-5965.
57. Crotti A., Neri F., Corti D., Ghezzi S., Heltai S., Baur A., Poli G., Santagostino E. and Vicenzi E. (2006) Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation. J. Virol. 80, 10663-10674.
58. Carl S., Greenough T. C., Krumbiegel M., Greenberg M., Skowronski J., Sullivan J. L. and Kirchhoff F. (2001) Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J. Virol. 75, 3657-3665.
59. Patel P. G., Kimata M. T., Biggins J. E., Wilson J. M. and Kimata J. T. (2002) Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens. J. Virol. 76, 6425-6434.
60. Weiss A. and Littman D. R. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274.
61. Argañaraz E. R., Schindler M., Kirchhoff F. and Lama. J. (2003) Enhanced CD4 down-modulation by late-stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J. Biol. Chem. 36, 33912-33919.
62. Bour S., Perrin C. and Strebel K. (1999) Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J. Biol. Chem. 274, 33800-33806.
63. Cortes M. J., Wong-Staal F. and Lama J. (2002) Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J. Biol. Chem. 277, 1770-1779.
64. Lama J., Mangasarian A. and Trono D. (1999) Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9, 622-631.
65. Levesque K., Zhao Y. S. and Cohen E. A. (2003) Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J. Biol. Chem. 278, 28346-28353.
66. Ross T. M., Oran A. E. and Cullen B. R. (1999) Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9, 613-621.
67. + T-cell depletion in human lymphoid tissue ex vivo. J. Virol. 75, 10113-10117.
68. Lundquist C. A., Tobiume M., Zhou J., Unutmaz D. and Aiken C. (2002) Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J. Virol. 76, 4625-4633.
69. Aiken C. and Trono D. (1995) Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056.
70. Schwartz O., Marechal V., Danos O. and Heard J. M. (1995) Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059.
71. LeGuern M. and Levy J. (1992) Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: Pseudotype virions produced with expanded cellular host range. Proc. Natl. Acad. Sci. USA 89, 363-367.
72. Michel N., Allespach I., Venzke S., Fackler O. T. and Keppler O. T. (2005) The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 15, 714-723.
73. Le Gall S., Buseyne F., Trocha A., Walker B. D., Heard J. M. and Schwartz O. (2000) Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation. J. Virol. 74, 9256-9266.
74. Williams M., Roeth J. F., Kasper M. R., Fleis R. I., Przybycin C. G. and Collins K. L. (2002) Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J. Virol. 76, 12173-12184.
75. Blagoveshchenskaya A. D., Thomas L., Feliciangeli S. F., Hung C. H. and Thomas G. (2002) HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111, 853-866.
76. Kasper M. R. and Collins K. L. (2003) Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells. J. Virol. 77, 3041-3049.
77. Kasper M. R., Roeth J. F., Williams M., Filzen T. M., Fleis R. I. and Collins K. L (2005) HIV-1 Nef disrupts antigen presentation early in the secretory pathway. J. Biol. Chem. 280, 12840-12848.
78. Larsen J. E., Massol R. H., Nieland T. J. and Kirchhausen T. (2004) HIV Nef-mediated major histocompatibility complex class I down-modulation is independent of Arf6 activity. Mol. Biol. Cell 15, 323-331.
79. Le Gall S., Erdtmann L., Benichou S., Berlloz-Torrent C., Liu L., Benarous, R., Heard J. M. and Schwartz O. (1998) Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8, 483-495.
80. Lubben N. B., Sahlender D. A., Motley A. M., Lehner P. J., Benaroch P. and Robinson M. S. (2007) HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1, and is impeded by AP-2. Mol. Biol. Cell 18, 3351-3365.
81. Mangasarian A., Piguet V., Wang J. K., Chen Y. L. and Trono D. (1999) Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73, 1964-1973.
82. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G. and Trono D. (2000) HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2, 163-167.
83. Roeth J. F., Williams M., Kasper M. R. Filzen T. M. and Collins K. L. (2004) HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167, 903-913.
84. Collins K. L., Chen B. K., Kalams S. A., Walker B. D. and Baltimore D. (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397-401.
85. Yang O. O., Nguyen P. T., Kalams S. A., Dorfman T., Gottlinger H. G., Stewart S., Chen I. S., Threlkeld S. and Walker B. D. (2002) Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J. Virol. 76, 1626-1631.
86. Cohen G. B., Gandhi R. T., Davis D. M., Mandelboim O., Chen B. K., Strominger J. L. and Baltimore D. (1999) The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671.
87. Specht A., Degottardi M. Q., Schindler M., Hahn B. H., Evans D. T. and Kirchhoff F. (2008) Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses. Virology 373, 229-237.
88. Degottardi M. Q., Specht A., Metcalf B., Kaur A., Kirchhoff F. and Evans D. T. (2008) Selective downregulation of rhesus macaque and sooty mangabey MHC class I molecules by Nef alleles of the SIVsmm/mac and HIV-2 lineage. J. Virol. 82, 3139-3146.
89. Fellay J., Shianna K. V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., Cozzi-Lepri A., De Luca A., Easterbrook P., Francioli P., Mallal S., Martinez-Picado J., Miro J. M., Obel N., Smith J. P., Wyniger J., Descombes P., Antonarakis S. E., Letvin N. L., McMichael A. J., Haynes B. F., Telenti A. and Goldstein D. B. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317, 944-947.
90. Münch J., Stolte N., Fuchs D., Stahl-Hennig C. and Kirchhoff F. (2001) Efficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques. J. Virol. 75, 10532-10536.
91. Swigut T., Alexander L., Morgan J., Lifson J., Mansfield K. G., Lang S., Johnson R. P., Skowronski J. and Desrosiers R. (2004) Impact of Nef-mediated downregulation of major histocompatibility complex class I on immune response to simian immunodeficiency virus. J. Virol. 78, 13335-13344.
92. Dyer W. B., Ogg G. S., Demoitie M. A., Jin X., Geczy A. F., Rowland-Jones S. L., McMichael A. J., Nixon D.F. and Sullivan, J. S. (1999) Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J. Virol. 73, 436-443.
93. Swigut T., Shohdy N. and Skowronski J. (2001) Mechanism for down-regulation of CD28 by Nef. EMBO J. 20, 1593-1604.
94. Bell I., Schaefer T. M., Trible R. P., Amedee A. and Reinhart T. A. (2001) Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283, 148-158.
95. Hrecka K., Swigut T., Schindler M., Kirchhoff F. and Skowronski J. (2005) Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to SDF-1 chemokine. J. Virol. 79, 10650-10659.
96. Michel, N., Ganter, K., Venzke, S., Bitzegeio, J., Fackler, O. T. and Keppler, O. T. (2006) The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling. Mol. Biol. Cell 17, 3578-3590.
97. Whatmore A. M., Cook N., Hall G. A., Sharpe S., Rud E. W. and Cranage M. P. (1995) Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69, 5117-5123.
98. Schindler M., Münch J., Brenner M., Stahl-Hennig C., Skowronski J. and Kirchhoff F. (2004) Comprehensive analysis of Nef functions selected in simian immunodeficiency virus-infected macaques. J. Virol. 78, 10588-10597.
99. Janardhan A., Swigut T., Hill B., Myers M. P. and Skowronski J. (2004). HIV-1 Nef binds the DOCK2-ELMO1 complex to activate Rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2: E6.
100. Venzke S., Michel N., Allespach I., Fackler O. T. and Keppler O. T. (2006) Expression of Nef downregulates CXCR4, the major coreceptor of human immunodeficiency virus, from the surfaces of target cells and thereby enhances resistance to superinfection. J. Virol. 80, 11141-11152.
101. Philpott S. M. (2003) HIV-1 coreceptor usage, transmission, and disease progression. Curr. HIV Res. 1, 217-227.
102. Gandhi R. T. and Walker B. D. (2002). Immunologic control of HIV-1. Annu. Rev. Med. 53:149-172.
103. Brander C. and Walker B. D. (1999) T lymphocyte responses in HIV-1 infection: Implications for vaccine development. Curr. Opin. Immunol. 4, 451-459.
104. Roche P. A., Teletski C. L., Karp D. R., Pinet V., Bakke O. and Long E. O. (1992) Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J. 11, 2841-2847.
105. Stumptner-Cuvelette P. and Benaroch P. (2002) Multiple roles of the invariant chain in MHC class II function. Biochim. Biophys. Acta 1542, 1-13.
106. + T-cell responses: Relationship to viral load in untreated HIV infection. J. Virol. 75, 11983-11991.
107. Schindler M., Wildum S., Casartelli N., Doria M. and Kirchhoff F. (2007) Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors. AIDS 21, 1103-1107.
108. Swingler S., Mann A., Jacque J., Brichacek B., Sasseville V. G., Williams K., Lackner A. A., Janoff E. N., Wang R., Fisher D. and Stevenson M. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat. Med. 5, 997-1103.
109. Swingler S., Brichacek B., Jacque J. M., Ulich C., Zhou J. and Stevenson M. (2003) HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 424, 213-219.
110. Simmons A, Aluvihare V. and McMichael A. (2001) Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763-777.
111. Glushakova S., Grivel J. C., Suryanarayana K., Meylan P., Lifson J. D., Desrosiers R. C. and Margolis L. (1999) Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo. J. Virol. 73, 3968-3974.
112. Pandori M. W., Fitch N. J. S., Craig H. M., Richman D. D., Spina C. A. and Guatelli J. C. (1996) Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283-4290.
113. Aiken C. (1997) Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 71, 5871-5877.
114. Chazal N., Singer G., Aiken C., Hammarskjold M. L. and Rekosh. D. (2001) Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J. Virol. 75, 4014-4018.
115. Welker R., Harris M., Cardel B. and Krausslich H. G. (1998) Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: Analysis of its role in enhancement of viral infectivity. J. Virol. 72, 8833-8840.
116. Fackler O. T., Moris A., Tibroni N., Giese S. I., Glass B., Schwartz O. and Krausslich H. G. (2006) Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351, 322-339.
117. Schaeffer E., Geleziunas R. and Greene W. C. (2001) Human immunodeficiency type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions. J. Virol. 75, 2993-3000.
118. Zheng Y. H., Plemenitas A., Fielding C. J. and Peterlin. B. M. (2003) Nef increases the synthesis of and transports cholesterol to lipid rafts and HIV-1 progeny virions. Proc. Natl. Acad. Sci. USA 100, 8460-8465.
119. Qi M. and Aiken C. (2007) Selective restriction of Nef-defective human immunodeficiency virus type 1 by a proteasome-dependent mechanism. J. Virol. 81, 1534-1536.
120. Campbell E. M., Nunez, R. and Hope T. J. (2004) Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J. Virol. 78, 5745-5755.
121. Pizzato M., Helander A., Popova E., Calistri A., Zamborlini A., Palù G. and Göttlinger H.G. (2007) Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc. Natl. Acad. Sci. USA 104:6812-6817.
122. Münch J., Rajan D., Schindler M., Specht A., Rücker E., Novembre F. J., Nerrienet E., Müller-Trutwin M. C., Peeters M., Hahn B. H. and Kirchhoff F. (2007) Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses. J. Virol. 81, 13852-13864.
123. Schindler M., Rajan D., Specht A., Ritter C., Pulkkinen K., Saksela K. and Kirchhoff F. (2007) Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue. J. Virol. 81, 13005-13014.
124. Arganaraz E. R., Schindler M., Kirchhoff F., Cortes M. J. and Lama J. (2003) Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication. J. Biol. Chem. 278, 33912-33919.
125. Du Z., Lang S. M., Sasseville V. G., Lackner A., Ilyinskii P. O., Daniel M. D. and Desrosiers R. C. (1995) Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674.
126. Dehghani H., Brown C. R., Plishka R., Buckler-White A. and Hirsch V. M. (2002) The ITAM in Nef influences acute pathogenesis of AIDS-inducing simian immunodeficiency viruses SIVsm and SIVagm without altering kinetics or extent of viremia. J. Virol. 76, 4379-4389.
127. Wu Y. and Marsh J. W. (2001) Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293, 1503-1506.
128. Hahn B. H., Shaw G. M., De Cock K. M. and Sharp P. M. (2000) AIDS as a zoonosis: Scientific and public health implications. Science 287, 607-614.
129. Sharp P. M, Shaw G. M. and Hahn B. H. (2005) Simian immunodeficiency virus infection of chimpanzees. J. Virol. 79, 3891-3902.
130. Hirsch V. M. (2004) What can natural infection of African monkeys with SIV tell us about the pathogenesis of AIDS? AIDS Rev. 6, 40-53.
131. Silvestri G. (2005). Naturally SIV-infected sooty mangabeys: Are we closer to understanding why they do not develop AIDS? J. Med. Primatol. 34, 243-252.
132. Leitner T., Foley B., Hahn B., Marx P., McCutchan F., Mellors J., Wolinsky S. and Korber B. (2003) HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 04-7420.
133. Bresnahan P. A., Yonemoto W. and Greene W. C. (1999) Cutting edge: SIV Nef protein utilizes both leucine- and tyrosine-based protein sorting pathways for down-regulation of CD4. J. Immunol. 163, 2977-2981.
134. Hua J. and Cullen B. R. (1997) Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J. Virol. 71, 6742-6748.
135. Lock M., Greenberg M. E., Iafrate A. J., Swigut T., Münch J., Kirchhoff F., Shohdy N. and Skowronski J. (1999) Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J. 18, 2722-2733.
136. Bailes E., Gao F., Bibollet-Ruche F., Courgnaud V., Peeters M., Marx P. A., Hahn B. H. and Sharp, P. M. (2003) Hybrid origin of SIV in chimpanzees. Science 300, 1713.
137. Neil S. J., Zang T. and Bieniasz P. D. (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430.
138. Grakoui A., Bromley S. K., Sumen C., Davis M. M., Shaw A. S., Allen P. M and Dustin M. L. (1999) The immunological synapse: A molecular machine controlling T cell activation. Science 285, 221-227.
139. Huppa J. B. and Davis M. M. (2003) T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3, 973-983.
140. Djordjevic J. T., Schibeci S. D., Stewart G. J., Williamson P. (2004) HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. AIDS Res. Hum. Retroviruses 20, 547-555.
141. Fenard D., Yonemoto W., de Noronha C., Cavrois M., Williams S. A. and Greene W. C. (2005) Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175, 6050-6057.
142. + T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. J. Biol. Chem. 279, 39520-39531.
143. Krautkramer E., Giese S. I., Gasteier J. E., Muranyi W. and Fackler O. T. (2004) Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78, 4085-4097.
144. Manninen A., Renkema G. H. and Saksela K. (2000) Synergistic activation of NFAT by HIV-1 Nef and the Ras/MAPK pathway. J. Biol. Chem. 275, 16513-16517.
145. Schrager J. A. and Marsh J. W. (1999) HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. USA 96, 8167-8172.
146. Wang J. K., Kiyokawa E., Verdin E. and Trono D. (2000) Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. USA 97, 394-399.
147. Thoulouze M. I., Sol-Foulon N., Blanchet F., Dautry-Varsat A., Schwartz O. and Alcover A. (2006) Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 24, 547-561.
148. Hanna Z., Kay D. G., Rebai N., Guimond A., Jothy S. and Jolicoeur P. (1998) Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175.
149. Learmont J. C., Geczy A. F., Mills J., Ashton L. J., Raynes-Greenow C. H., Garsia R. J., Dyer W. B., McIntyre L., Oelrichs R. B., Rhodes D. I., Deacon N. J. and Sullivan J. S. (1999) Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N. Engl. J. Med. 340, 1715-1722.
150. Bailes E., Chaudhuri R. R., Santiago M. L., Bibollet-Ruche F., Hahn B. H. and Sharp P. M. (2002) The evolution of primate lentiviruses and the origins of AIDS. In: The Molecular Epidemiology of Human Viruses, pp. 65-96, Leitner T. (ed.), Kluwer Academic Publishers, Norwell.
151. Gao F., Yue L., White A. T., Pappas P. G., Barchue J., Greene B. M.,
152. Gao F., Bailes E., Robertson D. L., Chen Y., Rodenburg C. M., Michael S. F., Cummins L. B., Arthur L. O., Peeters M., Shaw G. M., Sharp P. M. and Hahn B. H. (1999) Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 397, 436-441.
153. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Hunt R., Waldron L. M., MacKey J. J., Schmidt D. K., Chalifoux L. V. and King N. W. (1985) Isolation of T cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204.
154. Stevenson M. (2003) HIV-1 pathogenesis. Nat. Med. 9, 853-860.
155. Giorgi J. V., Hultin L. E., McKeating J. A., Johnson T. D., Owens B., Jacobson L. P., Shih R., Lewis J., Wiley D. J., Phair J. P., Wolinsky S. M. and Detels R. (1999) Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179, 859-870.
156. Sousa A. E., Carneiro J., Meier-Schellersheim M., Grossman Z. and Victorino R. M. (2002) CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169, 3400-3406.
157. Lama J. and Planelles V. (2007). Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 4:52.
158. Desrosiers R. C. and Ringler D. J. (1989) Use of SIVs for AIDS research. Intervirology 30, 301-312.
159. Silvestri G., Fedanov A., Germon S., Kozyr N., Kaiser W. J., Garber D. A., McClure H., Feinberg M. B. and Staprans S. I. (2005) Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J. Virol. 79, 4043-4054.
160. Kirchhoff F., Carl S., Kuhn E. M., Nißlein T., Hunsmann G. and Stahl-Hennig C. (1999) Emergence of the acute pathogenic SIVmac239 Nef R16Y variant in a rapidly progressing macaque with exceedingly high levels of plasma viremia. Virology 257, 61-70.
161. Münch J., Janardhan A., Stolte N., Stahl-Hennig C., Ten Haaft P., Heeney J. L., Swigut T., Kirchhoff F. and Skowronski J. (2002) T cell receptor:CD3 down-regulation is a selected in vivo function of SIV Nef but is not sufficient for effective viral replication in rhesus macaques. J. Virol. 76, 12360-12364.
162. Marlink R. G., Ricard D., Boup S. M., Kanki P. J., Romet-Lemonne J. L., Doye I. N., Diop K., Simpson M. A., Greco, F. and Chou M. J. (1988) Clinical, hematological, and immunologic cross sectional evaluation of individuals exposed to HIV-2. AIDS Res. Hum. Retroviruses 4, 137-148.
163. Michel P., Balde A. T., Roussilhon C., Aribot G., Sarthou J. L. and Gougeon M. L. (2000) Reduced immune activation and T cell apoptosis in HIV-2 compared with type 1: Correlation of T cell apoptosis with beta2 microglobulin concentration and disease evolution. J. Infect. Dis. 181, 64-75.
164. Silvestri G., Sodora D. L., Koup R. A., Paiardini M., O'Neil S. P., McClure H.M., Staprans S. I. and Feinberg M. B. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18, 441-452.
165. Switzer W. M., Wiktor S., Soriano V., Silva-Graca A., Mansinho K. and Coulibaly I. M. (1998) Evidence of Nef truncation in human immunodeficiency virus type 2 infection. J. Infect. Dis. 177, 65-71.
166. Alabi A. S., Jaffar S., Ariyoshi K., Blanchard T., Schim van der Loeff M., Awasana A. A., Corrah T., Sabally S., Sarge-Njie R., Cham-Jallow F., Jaye A., Berry N. and Whittle H. (2003) Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 17, 1513-1520.
167. Popper S. J., Sarr A. D., Gueye-Ndiaye A., Mboup S., Essex M. E. and Kanki P. J. (2000) Low plasma human immunodeficiency virus type 2 viral load is independent of proviral load: Low virus production in vivo. J. Virol. 74, 1554-1557.
168. Popper S. J., Sarr A. D., Travers K. U., Gueye-Ndiaye A., Mboup S., Essex M. E. and Kanki P. J. (1999) Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2. J. Infect. Dis. 180, 1116-1121.
169. Simon F., Matheron S., Tamalet C., Loussert-Ajaka I., Bartczak S., Pepin J. M., Dhiver C., Gamba E., Elbim C. and Gastaut J. (1993) Cellular and plasma viral load in patients infected with HIV-2. AIDS 7, 1411-1417.
170. Nguyen D. H., Hurtado-Ziola N., Gagneux P. and Varki A. (2006) Loss of Siglec expression on T lymphocytes during human evolution. Proc. Natl. Acad. Sci. USA 103, 7765-7770.
171. Cohen J. (2006) Immunology. Differences in immune cell "brakes" may explain chimp-human split on AIDS. Science 312, 672-673.
172. Ling B., Apetrei C., Pandrea I., Veazey R. S., Lackner A. A., Gormus B. and Marx P. A. (2004) Classic AIDS in a sooty mangabey after an 18 year natural infection. J. Virol. 78, 8902-8908.
173. Bibollet-Ruche F., Bailes E., Gao F., Pourrut X., Barlow K. L., Clewley, J. P., Clewley J. P., Mwenda J. M., Langat D. K., Chege G. K., McClure H. M., Mpoudi-Ngole E., Delaporte E., Peeters M., Shaw G. M., Sharp P. M. and Hahn B. H. (2004) New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): Evidence for a cercopithecus monkey virus clade. J. Virol. 78, 7748-7762.
174. Aghokeng A. F., Liu W., Bibollet-Ruche F., Loul S., Mpoudi-Ngole E., Laurent C., Mwenda J. M., Langat D. K., Chege G. K., McClure H. M., Delaporte E., Shaw G. M., Hahn B. H. and Peeters M. (2006) Widely varying SIV prevalence rates in naturally infected primate species from Cameroon. Virology 345, 174-189.
175. Alexander L., Du Z., Howe A. Y., Czajak S. and Desrosiers R. C. (1999) Induction of AIDS in rhesus monkeys by a recombinant SIV expressing nef of HIV-1. J. Virol. 73, 5814-5825.
176. Kirchhoff F., Münch J., Carl S., Stolte N., Mätz-Rensing K., Fuchs D., Haaft P. T., Heeney J. L., Swigut T., Skowronski J. and Stahl-Hennig C. (1999) The HIV-1 nef gene can to a large extent substitute for the SIV nef in vivo. J. Virol. 73, 8371-8383.
177. Mandell C. P., Reyes R. A., Cho K., Sawai E. T., Fang A. L., Schmidt K. A. and Luciw P. A. (1999) SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques. Virology 265, 235-251.
178. Sorin M. and Kalpana G. V. (2006). Dynamics of virus-host interplay in HIV-1 replication. Curr. HIV Res. 4, 117-130.
179. Brass A. L., Dykxhoorn D. M., Benita Y., Yan N., Engelman A., Xavier R. J., Lieberman J. and Elledge S. J. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926.
180. Daniel M. D., Kirchhoff F., Czajak S. C., Sehgal P. K. and Desrosiers R. C. (1992) Protective effects of a live-attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.